{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T06:17:52Z","timestamp":1793513872745,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Today, it is anticipated most individuals diagnosed with single-ventricle malformation will survive surgical reconstruction through a successful Fontan operation. As greater numbers of patients survive, so has the recognition that individuals with Fontan circulation face a variety of challenges. The goal of a normal quality and duration of life will not be reached by all. The hurdles fall into a variety of domains. From a cardiovascular perspective, the Fontan circulation is fundamentally flawed by its inherent nature of creating a state of chronically elevated venous pressure and congestion, accompanied by a relatively low cardiac output. Ventricular dysfunction, atrioventricular valve regurgitation, and arrhythmia may directly impact cardiac performance and can progress with time. Problems are not limited to the cardiovascular system. Fontan circulatory physiology impacts a multitude of biological processes and health parameters outside the heart. The lymphatic circulation is under strain manifesting as variable degrees of protein-rich lymph loss and immune system dysregulation. Organ system dysfunction develops through altered perfusion profiles. Liver fibrosis is ubiquitous, and a process of systemic fibrogenesis in response to circulatory stressors may affect other organs as well. Somatic growth and development can be delayed. Behavioral and mental health problems are common, presenting as clinically important levels of anxiety and depression. Most striking is the high variability in prevalence and magnitude of these complications within the population, indicating the likelihood of additional factors enhancing or mitigating their emergence. We propose that optimal care for the individual with single ventricle and a Fontan circulation is ideally offered in a comprehensive multidisciplinary manner, with attention to elements that are beyond cardiac management alone. In this report, we share the concepts, our experiences, and perspectives on development of a clinic model\u2014the \u201cFontan rehabilitation, wellness and resilience development\u201d or FORWARD program. We provide insights into the mechanics of our multidisciplinary model of care and the benefits offered serving our growing population of individuals with a Fontan circulation and their families.<\/jats:p>","DOI":"10.1007\/s00246-022-02930-z","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T11:04:16Z","timestamp":1653303856000},"page":"1175-1192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A Path FORWARD: Development of a Comprehensive Multidisciplinary Clinic to Create Health and Wellness for the Child and Adolescent with a Fontan Circulation"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8625-6565","authenticated-orcid":false,"given":"Jack","family":"Rychik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Rand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna E.","family":"Mancilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Heimall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Seivert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"O\u2019Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Dodds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"key":"2930_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009145","volume":"7","author":"MY Liu","year":"2018","unstructured":"Liu MY, Zielonka B, Snarr BS, Zhang X, Gaynor JW, Rychik J (2018) Longitudinal assessment of outcome from prenatal diagnosis through Fontan operation for over 500 fetuses with single ventricle-type congenital heart disease: the Philadelphia Fetus-to-Fontan cohort study. J Am Heart Assoc 7:e009145","journal-title":"J Am Heart Assoc"},{"key":"2930_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jtcvs.2017.01.056","volume":"154","author":"TE Downing","year":"2017","unstructured":"Downing TE, Allen KY, Glatz AC et al (2017) Long-term survival after the Fontan operation: twenty years of experience at a single center. J Thorac Cardiovasc Surg 154:243-253 e2","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2930_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000696","author":"J Rychik","year":"2019","unstructured":"Rychik J, Atz AM, Celermajer DS et al (2019) Evaluation and management of the child and adult with Fontan circulation: a scientific statement from the American Heart Association. Circulation. https:\/\/doi.org\/10.1161\/CIR.0000000000000696","journal-title":"Circulation"},{"key":"2930_CR4","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1200\/JCO.2006.07.3114","volume":"24","author":"AT Meadows","year":"2006","unstructured":"Meadows AT (2006) Pediatric cancer survivorship: research and clinical care. J Clin Oncol 24:5160\u20135165","journal-title":"J Clin Oncol"},{"key":"2930_CR5","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00246-012-0315-7","volume":"33","author":"J Rychik","year":"2012","unstructured":"Rychik J, Veldtman G, Rand E et al (2012) The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol 33:1001\u20131012","journal-title":"Pediatr Cardiol"},{"key":"2930_CR6","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1016\/j.jacc.2017.10.045","volume":"70","author":"CJ Daniels","year":"2017","unstructured":"Daniels CJ, Bradley EA, Landzberg MJ et al (2017) Fontan-associated liver disease: proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC. J Am Coll Cardiol 70:3173\u20133194","journal-title":"J Am Coll Cardiol"},{"key":"2930_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1161\/CIRCULATIONAHA.120.045597","volume":"142","author":"J Emamaullee","year":"2020","unstructured":"Emamaullee J, Zaidi AN, Schiano T et al (2020) Fontan-associated liver disease: screening, management, and transplant considerations. Circulation 142:591\u2013604","journal-title":"Circulation"},{"key":"2930_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004809","author":"DJ Goldberg","year":"2017","unstructured":"Goldberg DJ, Surrey LF, Glatz AC et al (2017) Hepatic fibrosis is universal following Fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.116.004809","journal-title":"J Am Heart Assoc"},{"key":"2930_CR9","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1161\/CIRCULATIONAHA.121.056870","volume":"144","author":"M Nii","year":"2021","unstructured":"Nii M, Inuzuka R, Inai K et al (2021) Incidence and expected probability of liver cirrhosis and hepatocellular carcinoma after Fontan operation. Circulation 144:2043\u20132045","journal-title":"Circulation"},{"key":"2930_CR10","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/chd.12831","volume":"14","author":"A Lemmer","year":"2019","unstructured":"Lemmer A, VanWagner L, Gasanova Z, Helmke S, Everson GT, Ganger D (2019) Assessing hepatic impairment in Fontan-associated liver disease using the HepQuant SHUNT test. Congenit Heart Dis 14:978\u2013986","journal-title":"Congenit Heart Dis"},{"key":"2930_CR11","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1007\/s00247-020-04776-0","volume":"50","author":"JR Dillman","year":"2020","unstructured":"Dillman JR, Trout AT, Alsaied T, Gupta A, Lubert AM (2020) Imaging of Fontan-associated liver disease. Pediatr Radiol 50:1528\u20131541","journal-title":"Pediatr Radiol"},{"key":"2930_CR12","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1007\/s00261-017-1181-9","volume":"42","author":"ML Wells","year":"2017","unstructured":"Wells ML, Hough DM, Fidler JL, Kamath PS, Poterucha JT, Venkatesh SK (2017) Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma. Abdom Radiol (NY) 42:2623\u20132631","journal-title":"Abdom Radiol (NY)"},{"key":"2930_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.cjco.2020.04.011","volume":"2","author":"AC Egbe","year":"2020","unstructured":"Egbe AC, Miranda WR, Veldtman GR, Graham RP, Kamath PS (2020) Hepatic venous pressure gradient in Fontan physiology has limited diagnostic and prognostic significance. CJC Open 2:360\u2013364","journal-title":"CJC Open"},{"key":"2930_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.humpath.2016.07.006","volume":"57","author":"LF Surrey","year":"2016","unstructured":"Surrey LF, Russo P, Rychik J et al (2016) Prevalence and characterization of fibrosis in surveillance liver biopsies of patients with Fontan circulation. Hum Pathol 57:106\u2013115","journal-title":"Hum Pathol"},{"key":"2930_CR15","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s00247-018-4311-9","volume":"49","author":"A Srinivasan","year":"2019","unstructured":"Srinivasan A, Guzman AK, Rand EB et al (2019) Percutaneous liver biopsy in Fontan patients. Pediatr Radiol 49:342\u2013350","journal-title":"Pediatr Radiol"},{"key":"2930_CR16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.21037\/atm.2016.12.27","volume":"4","author":"G Ndrepepa","year":"2016","unstructured":"Ndrepepa G, Kastrati A (2016) Gamma-glutamyl transferase and cardiovascular disease. Ann Transl Med 4:481","journal-title":"Ann Transl Med"},{"key":"2930_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13720","author":"E Martinez-Quintana","year":"2021","unstructured":"Martinez-Quintana E, Pardo-Maiza J, Deniz-Alvarado B, Riano-Ruiz M, Gonzalez-Martin JM, Rodriguez-Gonzalez F (2021) Gamma-glutamyl transferase and cardiovascular events in patients with congenital heart disease. Eur J Clin Investig. https:\/\/doi.org\/10.1111\/eci.13720","journal-title":"Eur J Clin Investig"},{"key":"2930_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jpeds.2021.04.019","volume":"235","author":"EE Mancilla","year":"2021","unstructured":"Mancilla EE, Zielonka B, Roizen JD et al (2021) Growth in children with a Fontan circulation. J Pediatr 235:149-155 e2","journal-title":"J Pediatr"},{"key":"2930_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/chd.12597","volume":"13","author":"SC Menon","year":"2018","unstructured":"Menon SC, Al-Dulaimi R, McCrindle BW et al (2018) Delayed puberty and abnormal anthropometry and its associations with quality of life in young Fontan survivors: a multicenter cross-sectional study. Congenit Heart Dis 13:463\u2013469","journal-title":"Congenit Heart Dis"},{"key":"2930_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1253\/circrep.CR-20-0009","volume":"2","author":"S Matsumura","year":"2020","unstructured":"Matsumura S, Yana A, Kuwata S et al (2020) Prevalence of short stature and growth hormone deficiency and factors associated with short stature after Fontan surgery. Circ Rep 2:243\u2013248","journal-title":"Circ Rep"},{"key":"2930_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bone.2015.04.012","volume":"77","author":"CM Avitabile","year":"2015","unstructured":"Avitabile CM, Goldberg DJ, Zemel BS et al (2015) Deficits in bone density and structure in children and young adults following Fontan palliation. Bone 77:12\u201316","journal-title":"Bone"},{"key":"2930_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jpeds.2021.06.068","volume":"238","author":"SS Vaikunth","year":"2021","unstructured":"Vaikunth SS, Leonard MB, Whitehead KK et al (2021) Deficits in the functional muscle-bone unit in youths with Fontan physiology. J Pediatr 238:202\u2013207","journal-title":"J Pediatr"},{"key":"2930_CR23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.athoracsur.2009.09.063","volume":"89","author":"D Thacker","year":"2010","unstructured":"Thacker D, Patel A, Dodds K, Goldberg DJ, Semeao E, Rychik J (2010) Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation. Ann Thorac Surg 89:837\u2013842","journal-title":"Ann Thorac Surg"},{"key":"2930_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1747-0803.2009.00320.x","volume":"5","author":"MJ Grattan","year":"2010","unstructured":"Grattan MJ, McCrindle BW (2010) Recurrent exacerbations of protein-losing enteropathy after initiation of growth hormone therapy in a Fontan patient controlled with spironolactone. Congenit Heart Dis 5:165\u2013167","journal-title":"Congenit Heart Dis"},{"key":"2930_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2020.10.058","author":"CE Tomasulo","year":"2020","unstructured":"Tomasulo CE, Chen JM, Smith CL, Maeda K, Rome JJ, Dori Y (2020) Lymphatic disorders and management in patients with congenital heart disease. Ann Thorac Surg. https:\/\/doi.org\/10.1016\/j.athoracsur.2020.10.058","journal-title":"Ann Thorac Surg"},{"key":"2930_CR26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jaip.2015.11.034","volume":"4","author":"MM Morsheimer","year":"2016","unstructured":"Morsheimer MM, Rychik J, Forbes L et al (2016) Risk factors and clinical significance of lymphopenia in survivors of the fontan procedure for single-ventricle congenital cardiac disease. J Allergy Clin Immunol Pract 4:491\u2013496","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2930_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jpeds.2015.04.061","volume":"167","author":"HS Magdo","year":"2015","unstructured":"Magdo HS, Stillwell TL, Greenhawt MJ et al (2015) Immune abnormalities in Fontan protein-losing enteropathy: a case-control study. J Pediatr 167:331\u2013337","journal-title":"J Pediatr"},{"key":"2930_CR28","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-1693","author":"VJ Gonzalez","year":"2021","unstructured":"Gonzalez VJ, Kimbro RT, Cutitta KE et al (2021) Mental health disorders in children with congenital heart disease. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2020-1693","journal-title":"Pediatrics"},{"key":"2930_CR29","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2241","author":"DR DeMaso","year":"2017","unstructured":"DeMaso DR, Calderon J, Taylor GA et al (2017) Psychiatric disorders in adolescents with single ventricle congenital heart disease. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2016-2241","journal-title":"Pediatrics"},{"key":"2930_CR30","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jtcvs.2013.12.019","volume":"147","author":"JW Gaynor","year":"2014","unstructured":"Gaynor JW, Ittenbach RF, Gerdes M et al (2014) Neurodevelopmental outcomes in preschool survivors of the Fontan procedure. J Thorac Cardiovasc Surg 147:1276\u20131282 (discussion 1282\u20131283 e5)","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2930_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/1359104520982323","volume":"26","author":"WL Ward","year":"2021","unstructured":"Ward WL, Smith A, Munns C, Bai S (2021) The process of integrating psychology into medical clinics: pediatric psychology as an example. Clin Child Psychol Psychiatry 26:323\u2013341","journal-title":"Clin Child Psychol Psychiatry"},{"key":"2930_CR32","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1001\/jamapediatrics.2015.1141","volume":"169","author":"JR Asarnow","year":"2015","unstructured":"Asarnow JR, Rozenman M, Wiblin J, Zeltzer L (2015) Integrated medical-behavioral care compared with usual primary care for child and adolescent behavioral health: a meta-analysis. JAMA Pediatr 169:929\u2013937","journal-title":"JAMA Pediatr"},{"key":"2930_CR33","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/jpepsy\/jsv083","volume":"41","author":"ME McGrady","year":"2016","unstructured":"McGrady ME, Hommel KA (2016) Targeting health behaviors to reduce health care costs in pediatric psychology: descriptive review and recommendations. J Pediatr Psychol 41:835\u2013848","journal-title":"J Pediatr Psychol"},{"key":"2930_CR34","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1542\/peds.2009-2973","volume":"126","author":"BS Marino","year":"2010","unstructured":"Marino BS, Tomlinson RS, Wernovsky G et al (2010) Validation of the pediatric cardiac quality of life inventory. Pediatrics 126:498\u2013508","journal-title":"Pediatrics"},{"key":"2930_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/0009922819890004","volume":"59","author":"K Burkhart","year":"2020","unstructured":"Burkhart K, Asogwa K, Muzaffar N, Gabriel M (2020) pediatric integrated care models: a systematic review. Clin Pediatr (Phila) 59:148\u2013153","journal-title":"Clin Pediatr (Phila)"},{"key":"2930_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016850","volume":"9","author":"SJ Weinreb","year":"2020","unstructured":"Weinreb SJ, Dodds KM, Burstein DS et al (2020) End-organ function and exercise performance in patients with Fontan circulation: what characterizes the high performers? J Am Heart Assoc 9:e016850","journal-title":"J Am Heart Assoc"},{"key":"2930_CR37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ijcard.2010.05.066","volume":"151","author":"EL Tay","year":"2011","unstructured":"Tay EL, Peset A, Papaphylactou M et al (2011) Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and\/or the Eisenmenger syndrome. Int J Cardiol 151:307\u2013312","journal-title":"Int J Cardiol"},{"key":"2930_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/2150135119890555","volume":"11","author":"J Rychik","year":"2020","unstructured":"Rychik J, Dodds KM, Goldberg D et al (2020) Protein losing enteropathy after Fontan operation: glimpses of clarity through the lifting fog. World J Pediatr Congenit Heart Surg 11:92\u201396","journal-title":"World J Pediatr Congenit Heart Surg"},{"key":"2930_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jacc.2008.02.081","volume":"52","author":"SM Paridon","year":"2008","unstructured":"Paridon SM, Mitchell PD, Colan SD et al (2008) A cross-sectional study of exercise performance during the first 2 decades of life after the Fontan operation. J Am Coll Cardiol 52:99\u2013107","journal-title":"J Am Coll Cardiol"},{"key":"2930_CR40","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s00246-020-02465-1","volume":"42","author":"DJ Goldberg","year":"2021","unstructured":"Goldberg DJ, Zak V, McCrindle BW et al (2021) Exercise capacity and predictors of performance after Fontan: results from the pediatric heart network Fontan 3 study. Pediatr Cardiol 42:158\u2013168","journal-title":"Pediatr Cardiol"},{"key":"2930_CR41","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1136\/heartjnl-2014-305723","volume":"100","author":"CM Avitabile","year":"2014","unstructured":"Avitabile CM, Leonard MB, Zemel BS et al (2014) Lean mass deficits, vitamin D status and exercise capacity in children and young adults after Fontan palliation. Heart 100:1702\u20131707","journal-title":"Heart"},{"key":"2930_CR42","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.ijcard.2012.10.012","volume":"168","author":"RL Cordina","year":"2013","unstructured":"Cordina RL, O\u2019Meagher S, Karmali A et al (2013) Resistance training improves cardiac output, exercise capacity and tolerance to positive airway pressure in Fontan physiology. Int J Cardiol 168:780\u2013788","journal-title":"Int J Cardiol"},{"key":"2930_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijcard.2021.09.019","volume":"343","author":"C Avitabile","year":"2021","unstructured":"Avitabile C, Goldmuntz E, Rychik J (2021) Exercise is medicine in the Fontan circulation. Int J Cardiol 343:50\u201352","journal-title":"Int J Cardiol"},{"key":"2930_CR44","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/2150135120978959","volume":"12","author":"TH Houlihan","year":"2021","unstructured":"Houlihan TH, Lopez S, Dodds K et al (2021) Living-related donor kidney transplant in a patient with single ventricle and Fontan circulation. World J Pediatr Congenit Heart Surg 12:673\u2013675","journal-title":"World J Pediatr Congenit Heart Surg"},{"key":"2930_CR45","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.115.019710","volume":"133","author":"Y Dori","year":"2016","unstructured":"Dori Y, Keller MS, Rome JJ et al (2016) Percutaneous lymphatic embolization of abnormal pulmonary lymphatic flow as treatment of plastic bronchitis in patients with congenital heart disease. Circulation 133:1160\u20131170","journal-title":"Circulation"},{"key":"2930_CR46","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1016\/j.jacc.2017.04.023","volume":"69","author":"M Itkin","year":"2017","unstructured":"Itkin M, Piccoli DA, Nadolski G et al (2017) Protein-losing enteropathy in patients with congenital heart disease. J Am Coll Cardiol 69:2929\u20132937","journal-title":"J Am Coll Cardiol"},{"key":"2930_CR47","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1017\/S1047951120001869","volume":"30","author":"T Alsaied","year":"2020","unstructured":"Alsaied T, Allen KY, Anderson JB et al (2020) The Fontan outcomes network: first steps towards building a lifespan registry for individuals with Fontan circulation in the United States. Cardiol Young 30:1070\u20131075","journal-title":"Cardiol Young"}],"updated-by":[{"DOI":"10.1007\/s00246-022-02952-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000}}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-022-02930-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-022-02930-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-022-02930-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T09:03:28Z","timestamp":1658135008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-022-02930-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2930"],"URL":"https:\/\/doi.org\/10.1007\/s00246-022-02930-z","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00246-022-02952-7","asserted-by":"object"}]},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,23]]},"assertion":[{"value":"22 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00246-022-02952-7","URL":"https:\/\/doi.org\/10.1007\/s00246-022-02952-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Goldberg is a named inventor on method of use patents regarding the use of udenafil in patients who have undergone Fontan palliation. Dr. Rychik is a consultant for Mezzion Pharmaceuticals, a company in search of solutions for challenges in the single ventricle population.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}